Results 91 to 100 of about 24,868 (172)

Efficacy and safety of echinocandins combined with Trimethoprim-Sulfamethoxazole as first-line treatment for Pneumocystis pneumonia in HIV-infected and non-HIV-infected patients. [PDF]

BMC Infect Dis
Xie J, Gao A, Zhang W, Zhao D, Liu W.
europepmc   +1 more source

Individualized Trimethoprim-Sulfamethoxazole Dosing in Non-HIV Patients with Pneumocystis Pneumonia: A Narrative Review of Current Evidence. [PDF]

J Pers Med
Dimeas IE, Dimeas GE, Zakynthinos GE, Tsolaki V.   +3 more
europepmc   +1 more source

Risk factors for adverse events associated with trimethoprim-sulfamethoxazole treatment for Pneumocystis pneumonia in non-human immunodeficiency virus-infected patients: a multicenter, retrospective, observational cohort study. [PDF]

BMC Infect Dis
Idemitsu R, Nagai T, Matsui H, Fujioka H, Homma Y, Otsuki A, Ito H, Ohmura S, Miyamoto T, Shichi D, Watari T, Otsuka Y, Nakashima K.   +12 more
europepmc   +1 more source

Pneumocystis Pneumonia and Disseminated Cryptococcosis Dual Infection: A Case Report. [PDF]

Cureus
Vieira Afonso JFF, Santos MM, Vieira J, Oliveira R, Rodrigues AF.   +4 more
europepmc   +1 more source

Alternative Pneumocystis Pneumonia Prophylaxis in Solid Organ Transplants. [PDF]

Transpl Infect Dis
He KD, Nguyen L, Norris M, Malat G, Witek S, Sammons C, Forte A, Claridge T, Clark JT, Blumberg E.   +9 more
europepmc   +1 more source

Pneumocystis Pneumonia-Is it Still a Threat Among People With Human Immunodeficiency Virus (HIV)? A Danish HIV Cohort Study. [PDF]

Open Forum Infect Dis
Møller AK, Schnoor SB, Petersen I, Martin-Iguacel R, Kronborg G, Larsen CS, Dalager-Pedersen M, Gerstoft J, Omland LH, Rasmussen LD.   +9 more
europepmc   +1 more source

Risk factors for identifying pneumocystis pneumonia in pediatric patients. [PDF]

Front Cell Infect Microbiol
Zhang C, Li Z, Chen X, Wang M, Yang E, Xu H, Wang S.   +6 more
europepmc   +1 more source

Pneumocystis pneumonia

Canadian Medical Association journal, 2010
openaire   +3 more sources

A Diagnostic Uncertainty in an Immunocompromised Patient: Rapidly Progressive Interstitial Lung Disease vs. Pneumocystis Pneumonia. [PDF]

Cureus
Shamasneh I, Al-Bahadili N, Amable F, Rezek M, McKown A.   +4 more
europepmc   +1 more source

Pneumocystis pneumonia

, 2016
openaire   +2 more sources